Poly Medicure dividend record date: Medical equipment manufacturer Poly Medicure Ltd has announced the much-awaited record date for its final dividend for the financial year 2024–25. The company’s board of directors, after its meeting on September 5, 2025, fixed Thursday, September 18, 2025 as the record date for its dividend payout.
This update is important for investors, as dividend announcements often influence stock price movements and investor sentiment. Let’s break down what this means for shareholders and potential investors.
🗓️ Record Date and Dividend Payout
The company’s filing to the BSE clarified the details of the dividend:
- Dividend Amount: ₹3.50 per share
- Face Value: ₹5 per equity share
- Record Date: Thursday, September 18, 2025
- Book Closure Period: From Friday, September 19, 2025, to Thursday, September 25, 2025 (both days inclusive)
👉 In simple terms, investors holding Poly Medicure shares as of September 17, 2025 (one day before the record date) will be eligible to receive the dividend.
💡 Example:
If an investor owns 100 shares of Poly Medicure, they will receive ₹350 (100 × ₹3.50) as dividend when the payout is credited.
📈 Poly Medicure Share Price Performance
On the day of the announcement, Poly Medicure’s stock closed at ₹2,041.50 on the BSE, up 0.12% compared to the previous close of ₹2,039.05. The news of the dividend was shared during the trading session on September 5, 2025, giving investors clarity about the company’s payout timeline.
🔹 52-Week Performance:
- High: ₹3,350 (1 November 2024)
- Low: ₹1,822.65 (13 August 2025)
This shows that the stock has seen significant volatility in the past year.
🔹 Long-Term Returns:
- 5-Year Return: +356% 🚀
- 1-Year Return: –20% 📉
- YTD (2025): –23.87%
- 1-Month Return: +2.78%
Despite recent corrections, the stock has created multibagger returns over the long term.
💰 Market Capitalisation
As of September 5, 2025, Poly Medicure’s market capitalisation stood at ₹20,685.64 crore. This positions it among the established players in India’s medical equipment sector, an industry expected to expand strongly in the coming decade.
🏥 About Poly Medicure Ltd
Poly Medicure, often referred to as Polymed, is a leading manufacturer of medical devices and disposables. The company is engaged in developing and producing products such as:
- IV Cannulae
- Infusion therapy products
- Blood management systems
- Dialysis consumables
- Diagnostic devices
🌍 With a strong export presence, Poly Medicure supplies to over 100 countries worldwide, making it a significant player in the global healthcare supply chain.
The company’s ability to consistently grow revenues and profits, along with a shareholder-friendly approach of paying dividends, has helped it earn investor trust over the years.
📊 Dividend History of Poly Medicure
Poly Medicure has maintained a steady dividend policy, reflecting its strong fundamentals and cash flow position.
Here’s a quick look at its dividend record:
| Financial Year | Dividend per Share (₹) | Face Value (₹) | Type |
|---|---|---|---|
| 2022–23 | 3.00 | 5 | Final Dividend |
| 2023–24 | 3.25 | 5 | Final Dividend |
| 2024–25 | 3.50 | 5 | Final Dividend 🚀 |
📌 The gradual increase shows that the company has been rewarding its shareholders consistently.
🔎 What Does This Mean for Investors?
- Steady Income Source: Investors holding shares can benefit from the dividend payout, adding passive income.
- Confidence Signal: Dividend announcements reflect management’s confidence in the company’s financial health.
- Entry Opportunity: Investors looking for exposure to the healthcare and medical equipment sector may find the correction in share price an opportunity.
- Tax Consideration: Dividends are taxable in the hands of shareholders as per their applicable income tax slab.
⚠️ Risks and Considerations
While Poly Medicure has strong fundamentals, investors must keep in mind:
- Stock Volatility: The stock has corrected over 20% in the last year.
- Sector Competition: Medical equipment is a competitive sector, with domestic and global players.
- Global Market Risks: Since the company exports heavily, currency fluctuations and global demand slowdowns may affect performance.
📰 Analyst View
Market analysts note that while the stock has faced short-term corrections, the long-term growth story remains intact due to rising demand for healthcare products in India and abroad.
Many brokerages maintain a positive outlook with a long-term target price range of ₹2,500–₹2,800, depending on earnings growth in FY26.
📌 Key Takeaways
- ✅ Dividend Declared: ₹3.50 per share (final dividend for FY 2024–25)
- ✅ Record Date: September 18, 2025
- ✅ Eligibility: Shareholders holding stock by September 17, 2025
- ✅ 5-Year Return: +356% despite recent correction
- ✅ Market Cap: ₹20,685.64 crore
📢 Final Word
Poly Medicure’s announcement of a ₹3.50 per share final dividend shows its commitment to rewarding investors. Despite recent volatility, the company’s strong fundamentals, global presence, and consistent dividend track record make it a notable player in India’s healthcare equipment sector.
For long-term investors, Poly Medicure remains a stock worth watching, while short-term traders should keep an eye on technical levels and market trends.
⚠️ Disclaimer: This article is for informational purposes only. It is not financial advice. Investors should consult certified financial experts before making investment decisions.
